Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2010

Conditions
Renal InsufficiencyKidney DiseasesUrologic Diseases
Interventions
DRUG

Udenafil

100mg Single Oral Dose of

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

lead

Asan Medical Center

OTHER